Nov 09, 2021 8:04am EST MAIA Biotechnology, Inc. Announces Poster Presentation at the Society for Immunotherapy of Cancer 36th Annual Meeting (SITC)
Sep 28, 2021 8:00am EDT MAIA Biotechnology, Inc. Announces the Appointment of Steven M. Chaouki to Its Board of Directors
Aug 17, 2021 4:05pm EDT MAIA Biotechnology, Inc. Appoints Joseph F. McGuire as Chief Financial Officer and Provides Corporate Update
Aug 04, 2021 4:12pm EDT MAIA Biotechnology, Inc. Announces Additions to Executive Team and Board of Directors
May 19, 2021 8:00am EDT MAIA Biotechnology, Inc. Raises $8.0 Million Financing to Advance Pipeline of Targeted Immuno-Oncology Studies
Feb 02, 2021 8:00am EST MAIA Biotechnology, Inc. Announces Clinical Supply Agreement with Regeneron for Phase 1/2 Clinical Trial Evaluating THIO in Sequential Administration with Libtayo® (cemiplimab) in Advanced Non-Small Cell Lung Cancer
